Is a long‐term high‐intensity exercise program effective and safe in patients with rheumatoid arthritis?: Results of a randomized controlled trialZuzana de Jong, Johanna M. W. Hazes, Marten Munneke et al.|Arthritis & Rheumatism|2003Cited by 299
A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritisJasper J. Haringman, Paul P. Tak, Daniëlle M. Gerlag et al.|Arthritis & Rheumatism|2006Cited by 255
Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placeboUmesh A. Badrising, Axel R. Wintzen, Marion L. C. Maat–Schieman et al.|Annals of Neurology|2002Cited by 132
A randomized comparison of care provided by a clinical nurse specialist, an inpatient team, and a day patient team in rheumatoid arthritisGerhardus J. Tijhuis, T. P. M. Vliet Vlieland, Aeilko H. Zwinderman et al.|Arthritis Care & Research|2002Cited by 112
The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8)Maarten C. Kraan, Paul P Tak, Jasper J. Haringman et al.|Arthritis Research & Therapy|2000Cited by 108